Tod Smeal
Chief Tech/Sci/R&D Officer en CARDIFF ONCOLOGY, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Tod Smeal is currently the Chief Scientific Officer at Cardiff Oncology, Inc. He previously held positions as the Director-Oncology Research Unit at Pfizer Inc. from 2003 to 2015, the Chief Scientific Officer at Eli Lilly & Co. from 2015 to 2020, and the Chief Scientific Officer at Hexagon Bio, Inc. from 2020 to 2021.
Dr. Smeal obtained his undergraduate degree from the Massachusetts Institute of Technology and his doctorate degree from the University of California San Diego.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
-.--% | 07/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Tod Smeal
| Empresas | Cargo | Inicio |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 11/01/2022 |
Antiguos cargos conocidos de Tod Smeal.
| Empresas | Cargo | Fin |
|---|---|---|
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2015 |
Formación de Tod Smeal.
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Tod Smeal
